Amiloride, sold under the trade name Midamor among others, is a medication typically used with other medications to treat high blood pressure or swelling due to heart failure or cirrhosis of the liver. Amiloride is classified as a potassium-sparing diuretic. Amiloride is often used together with another diuretic, such as a thiazide or loop diuretic. It is taken by mouth. Onset of action is about two hours and it lasts for about a day.
Common side effects include high blood potassium, vomiting, loss of appetite, rash, and headache. The risk of high blood potassium is greater in those with kidney problems, diabetes, and those who are older. Amiloride blocks the epithelial sodium channel (ENaC) in the late distal tubule, connecting tubule, and collecting duct of the nephron, which both reduces absorption of sodium ion from the lumen of the nephron and reduces excretion of potassium ion into the lumen.
Amiloride was developed in 1967. It is on the World Health Organization's List of Essential Medicines. |
Read full article at Wikipedia
|
InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15) |
XSDQTOBWRPYKKA-UHFFFAOYSA-N |
NC(=N)NC(=O)c1nc(Cl)c(N)nc1N |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
sodium channel blocker
An agent that inhibits sodium influx through cell membranes.
|
|
diuretic
An agent that promotes the excretion of urine through its effects on kidney function.
|
|
View more via ChEBI Ontology
3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide
|
amilorida
|
ChemIDplus
|
amiloride
|
WHO MedNet
|
amiloride
|
ChEBI
|
amiloridum
|
ChemIDplus
|
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
|
IUPAC
|
Amiloride
|
KEGG COMPOUND
|
N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide
|
ChemIDplus
|
158
|
DrugCentral
|
Amiloride
|
Wikipedia
|
AMR
|
PDBeChem
|
BE639386
|
Patent
|
C06821
|
KEGG COMPOUND
|
CPD-10324
|
MetaCyc
|
D07447
|
KEGG DRUG
|
DB00594
|
DrugBank
|
HMDB0014732
|
HMDB
|
LSM-4194
|
LINCS
|
US3313813
|
Patent
|
View more database links |
2609-46-3
|
CAS Registry Number
|
ChemIDplus
|
616612
|
Beilstein Registry Number
|
Beilstein
|
657410
|
Reaxys Registry Number
|
Reaxys
|
|